US Patent Issued to Viela Bio on June 9 for "Methods of treating immune-mediated pulmonary injury with an anti-ILT7 antibody" (Illinois Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,994, issued on June 9, was assigned to Viela Bio Inc. (Deerfield, Ill.).

"Methods of treating immune-mediated pulmonary injury with an anti-ILT7 antibody" was invented by Gabor Illei (Deerfield, Ill.), William Rees (Deerfield, Ill.) and Jorn Drappa (Deerfield, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods for treating or preventing immune-mediated pulmonary injury (IMPI) in a subject in need thereof, the method comprising administering to the subject an anti-Type I interferon (anti-T1i) therapy that blocks the activity, function or production of Type I interferon (T1i) in the subject, wherein the anti-T...